Health Care [ 4/12 ] | Biotechnology [ 21/75 ]
NASDAQ | Common Stock
Alpha Cognition Inc., a biopharmaceutical company, engages in the development of treatments for patients suffering from neurodegenerative diseases in the United States and Canada.
The company's commercial development program includes ZUNVEYL oral tablet formulation for treating Alzheimer's disease.
Its pre-clinical development programs comprise ZUNVEYL in combination with memantine for the treatment of moderate-to-severe Alzheimer's disease; ALPHA-1062 sublingual formulation for acute pancreatitis; ALPHA-1062 intranasal formulation for the treatment of cognitive impairment with mild traumatic brain injury; and ALPHA-0602, ALPHA-0702, and ALPHA-0802 programs for the treatment of neurodegenerative diseases, including amyotrophic lateral sclerosis disease and spinal muscular atrophy.
The company was founded in 2000 and is headquartered in Vancouver, Canada.
| Reported date | EPSChange YoY | EstimateSurprise |
|---|---|---|
| Nov 14, 25 | -0.30 Increased by +2.72% | -0.43 Increased by +30.23% |
| Aug 14, 25 | -0.65 Decreased by -160.00% | -0.74 Increased by +12.16% |
| May 15, 25 | -0.13 Increased by +85.07% | -0.54 Increased by +75.93% |
| Mar 31, 25 | -0.50 Increased by +41.62% | -0.48 Decreased by -4.17% |
| Nov 18, 24 | -0.31 Increased by +58.18% | - |
| Aug 13, 24 | -0.25 Increased by +58.18% | -1.00 Increased by +75.00% |
| May 15, 24 | -0.87 Increased by +42.52% | - |
| Nov 29, 23 | -0.86 Decreased by -12.29% | - |
| Fiscal ending date | RevenueChange YoY | IncomeChange YoY | ProfitChange YoY |
|---|---|---|---|
| Sep 30, 25 | 2.84 M Increased by +N/A% | -1.32 M Increased by +29.13% | Decreased by -46.40% Decreased by N/A% |
| Jun 30, 25 | 1.66 M Increased by +N/A% | -10.49 M Decreased by -395.81% | Decreased by -632.75% Decreased by N/A% |
| Mar 31, 25 | 2.93 M Increased by +N/A% | -2.01 M Increased by +59.86% | Decreased by -68.51% Decreased by N/A% |
| Dec 31, 24 | 0.00 Decreased by N/A% | -5.66 M Increased by +2.39% | Decreased by N/A% Decreased by N/A% |
| Sep 30, 24 | 0.00 Decreased by N/A% | -1.86 M Increased by +43.11% | Decreased by N/A% Decreased by N/A% |
| Jun 30, 24 | 0.00 Decreased by N/A% | -2.12 M Increased by +24.92% | Decreased by N/A% - |
| Mar 31, 24 | 0.00 Decreased by N/A% | -5.00 M Decreased by -168.53% | Decreased by N/A% - |
| Dec 31, 23 | 0.00 Decreased by N/A% | -5.80 M Decreased by -40.63% | Decreased by N/A% - |